Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2020 1
2021 4
2022 4
2023 3
2024 4
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Dapagliflozin in Patients with Chronic Kidney Disease.
Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, Sjöström CD, Toto RD, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Heerspink HJL, et al. N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24. N Engl J Med. 2020. PMID: 32970396 Free article. Clinical Trial.
Syndecan-3 as a Novel Biomarker in Alzheimer's Disease.
Hudák A, Letoha A, Vizler C, Letoha T. Hudák A, et al. Among authors: letoha a. Int J Mol Sci. 2022 Mar 21;23(6):3407. doi: 10.3390/ijms23063407. Int J Mol Sci. 2022. PMID: 35328830 Free PMC article.
Novel biomarkers of mitochondrial dysfunction in Long COVID patients.
Szögi T, Borsos BN, Masic D, Radics B, Bella Z, Bánfi A, Ördög N, Zsiros C, Kiricsi Á, Pankotai-Bodó G, Kovács Á, Paróczai D, Botkáné AL, Kajtár B, Sükösd F, Lehoczki A, Polgár T, Letoha A, Pankotai T, Tiszlavicz L. Szögi T, et al. Among authors: letoha a. Geroscience. 2025 Apr;47(2):2245-2261. doi: 10.1007/s11357-024-01398-4. Epub 2024 Nov 4. Geroscience. 2025. PMID: 39495479 Free PMC article.
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function.
Heerspink HJL, Cherney D, Postmus D, Stefánsson BV, Chertow GM, Dwyer JP, Greene T, Kosiborod M, Langkilde AM, McMurray JJV, Correa-Rotter R, Rossing P, Sjöström CD, Toto RD, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Heerspink HJL, et al. Kidney Int. 2022 Jan;101(1):174-184. doi: 10.1016/j.kint.2021.09.005. Epub 2021 Sep 22. Kidney Int. 2022. PMID: 34560136 Free article. Clinical Trial.
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.
Heerspink HJL, Sjöström CD, Jongs N, Chertow GM, Kosiborod M, Hou FF, McMurray JJV, Rossing P, Correa-Rotter R, Kurlyandskaya R, Stefansson BV, Toto RD, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Heerspink HJL, et al. Eur Heart J. 2021 Mar 31;42(13):1216-1227. doi: 10.1093/eurheartj/ehab094. Eur Heart J. 2021. PMID: 33792669 Free PMC article. Clinical Trial.
Syndecan-4 Mediates the Cellular Entry of Adeno-Associated Virus 9.
Hudák A, Roach M, Pusztai D, Pettkó-Szandtner A, Letoha A, Szilák L, Azzouz M, Letoha T. Hudák A, et al. Among authors: letoha a. Int J Mol Sci. 2023 Feb 5;24(4):3141. doi: 10.3390/ijms24043141. Int J Mol Sci. 2023. PMID: 36834552 Free PMC article.
18 results